Connect Biopharma (NASDAQ:CNTB) Stock Rating Reaffirmed as “Buy” by Canaccord Genuity Group
Connect Biopharma (NASDAQ:CNTB – Get Free Report)‘s stock had its “buy” rating reaffirmed by Canaccord Genuity Group in a research note issued to investors on Tuesday, Benzinga reports. CNTB has been the subject of several other research reports. Wall Street Zen downgraded Connect Biopharma from a “hold” rating to a “sell” rating in a research […]
17 Nov 16:56 · The Markets Daily